MedTrace Logo

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

NCT04941144 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8538

Last updated 2023-05-19

No results posted yet for this study

Summary

This study is a long-term follow-up survey of Japanese people after their second vaccination with the Moderna COVID-19 vaccine.

The study sponsor will not be involved in how the participants are treated but will provide instructions on how the clinics will record what happens during the study.

The main aim of the study is to check for long-term side effects of the COVID-19 vaccine. This will be from 28 days to 12 months after the second vaccination of the COVID-19 vaccine.

The number of visits to the clinic will depend on the clinic's standard practice.

Conditions

  • Coronavirus Disease (COVID-19)

Interventions

BIOLOGICAL

COVID-19 Vaccine

COVID-19 Vaccine Intramuscular Injection

Sponsors & Collaborators

  • ModernaTX, Inc.

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-22
Primary Completion
2023-04-28
Completion
2023-04-28
FDA Drug
Yes

Countries

  • Japan

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04941144 on ClinicalTrials.gov